Oxymetazoline Hydrochloride

CHEMBL1200791 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
296.8 g/mol
LogP
Phase
4

A hydrochloride salt form of oxymetazoline with the same therapeutic properties. A nasal decongestant providing up to 12 hours of congestion relief, limited to 3 days to avoid rebound.

Masse moléculaire

296,8300 g/mol

TPSA

44,60 Ų

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl

InChI

InChI=1S/C16H24N2O.ClH/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14;/h8,19H,6-7,9H2,1-5H3,(H,17,18);1H

Molecular Formula

C16H25ClN2O

HBD / HBA

3 / 2

Liaisons Rotatives

3

Atomes Lourds

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A hydrochloride salt form of oxymetazoline with the same therapeutic properties. A nasal decongestant providing up to 12 hours of congestion relief, limited to 3 days to avoid rebound.

Yes, Oxymetazoline Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200791. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 66259. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.